| Control (n = 13) | Stone patients | ||
---|---|---|---|---|
Before ESWL (n = 54) | 2 wk after ESWL (n = 44) | 4 wk after ESWL (n = 37) | ||
Age (years) | 54.5 ± 3.8 | 53.8 ± 3.0 |  |  |
BMI ((kg/m2) | 23.6 ± 0.4 | 23.5 ± 0.7 |  |  |
Stone size (mm) | 0 | 9.1 ± 2.3* |  |  |
Urine pH | 6.0 ± 0.1 | 6.2 ± 0.2 | 6.0 ± 0.2 | 6.1 ± 0.1 |
eGFR (ml/min/1.73 m²) | 88.3 ± 4.7 | 87.6 ± 5.4 | 88.2 ± 5.6 | 85.1 ± 4.6 |
APCaOx | 2.4 ± 0.9 | 4.7 ± 1.1* | 4.8 ± 1.1# | 4.7 ± 1.1+ |
Oxalate (mg/24 h) | 9.1 ± 1.8 | 40.4 ± 4.9* | 47.8 ± 7.5# | 44.6 ± 11.9+ |
Citric acid (mg/24 h) | 365.8 ± 42.1 | 102.4 ± 20.4* | 96.8 ± 13.1# | 86.9 ± 16.9+ |
Urine protein (g/24 h) | 0.09 ± 0.01 | 0.07 ± 0.02 | 0.07 ± 0.02 | 0.08 ± 0.01 |
αGST (µg/g Cr) | 5.3 ± 0.8 | 28.4 ± 5.9* | 26.3 ± 3.6# | 25.7 ± 3.3+ |
πGST (µg /g Cr) | 4.9 ± 0.6 | 22.8 ± 4.5* | 19.1 ± 4.1# | 20.7 ± 3.8+ |
MDA (µmol/g Cr) | 11.7 ± 2.4 | 44.5 ± 2.3* | 41.8 ± 2.2# | 39.8 ± 2.4+ |